6
Oct
2026
JAMP Pharma Corporation
Exhibitor at CPHI Milan 2026 stand 18A17, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Canada
-
On CPHI since:2019
-
Certificates:1
-
Employees:500 - 999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 18A17, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Nystatin oral suspension USP 100 000 units/mL
Antifungal. Registered with Health Canada. -
Product Calcium carbonate 500 mg caplets
Calcium - Carbonate. Registered with Health Canada. -
Product JAMP Cholestyramine
Cholestyramine for oral suspension 4 g/dose, USP. Registered with Health Canada. -
Product JAMP Flecainide
Flecainide acetate tablets 50 mg, 100mgAntiarrhythmic Agent. Registered with Health Canada. -
Product JAMP Hydralazine
Hydralazine Hydrochloride10 mg, 25mg, 50mg tablets Antihypertensive Agent. Registered with Health Canada.




